{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:18:47Z","timestamp":1779142727196,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Changsha Municipal Natural Science Foundation","award":["kq2014203"],"award-info":[{"award-number":["kq2014203"]}]},{"name":"Hunan Provincial People\u2019s Hospital Ren Shu Fund","award":["2015-2-11"],"award-info":[{"award-number":["2015-2-11"]}]},{"name":"Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics Project Fund","award":["2017TP1034"],"award-info":[{"award-number":["2017TP1034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Coronary heart disease (CHD) is the result of a complex metabolic disorder caused by various environmental and genetic factors, and often has anxiety as a comorbidity. Rupture of atherosclerotic plaque in CHD patients can lead to acute coronary syndrome (ACS). Anxiety is a known independent risk factor for the adverse cardiovascular events and mortality in ACS, but it remains unclear how stress-induced anxiety behavior impacts their blood plasma metabolome and contributes to worsening of CHD. The present study aimed to determine the effect of anxiety on the plasma metabolome in ACS patients. After receiving ethical approval 26 ACS patients comorbid anxiety were recruited and matched 26 ACS patients. Blood plasma samples were collected from the patients and stored at\u2009\u2212\u200980\u00a0\u00b0C until metabolome profiling. Metabolome analysis was performed by liquid chromatography mass spectrometry (LC\u2013MS), and the data were subjected to multivariate analysis. Disturbance of 39 plasma metabolites was noted in the ACS with comorbid anxiety group compared to the ACS group. These disturbed metabolites were mainly involved in tryptophan metabolism, pyrimidine metabolism, glycerophospholipid metabolism, pentose phosphate pathway, and pentose and glucuronate interconversions. The most significantly affected pathway was tryptophan metabolism including the down-regulation of tryptophan and serotonin. Glycerophospholipids metabolism, pentose and glucuronate interconversions, and pentose phosphate pathway were also greatly affected. These results suggest that anxiety can disturb three translation of material in ACS patients. Besides the above metabolism pathways pyrimidine metabolism was significantly disturbed. Based on the present findings the plasma metabolites monitoring can be recommended and may be conducive to early biomarkers detection for personalized treatment anxiety in CHD patients in future.<\/jats:p>","DOI":"10.1038\/s41598-021-92421-7","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T10:03:33Z","timestamp":1624010613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anxiety disturbs the blood plasma metabolome in acute coronary syndrome patients"],"prefix":"10.1038","volume":"11","author":[{"given":"HongYan","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JunYuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XueYao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LianHong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YiMin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BoYu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"92421_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth, G. A. et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J. Am. Coll. Cardiol. 70, 1\u201325. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.052 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"92421_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jpba.2015.04.021","volume":"113","author":"M Kordalewska","year":"2015","unstructured":"Kordalewska, M. & Markuszewski, M. J. Metabolomics in cardiovascular diseases. J. Pharm. Biomed. Anal. 113, 121\u2013136. https:\/\/doi.org\/10.1016\/j.jpba.2015.04.021 (2015).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"92421_CR3","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.jacc.2018.03.458","volume":"71","author":"IL Pi\u00f1a","year":"2018","unstructured":"Pi\u00f1a, I. L., Di Palo, K. E. & Ventura, H. O. Psychopharmacology and cardiovascular disease. J. Am. Coll. Cardiol. 71, 2346\u20132359. https:\/\/doi.org\/10.1016\/j.jacc.2018.03.458 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"92421_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s11886-016-0800-3","volume":"18","author":"PJ Tully","year":"2016","unstructured":"Tully, P. J., Harrison, N. J., Cheung, P. & Cosh, S. Anxiety and cardiovascular disease risk: A review. Curr. Cardiol. Rep. 18, 120. https:\/\/doi.org\/10.1007\/s11886-016-0800-3 (2016).","journal-title":"Curr. Cardiol. Rep."},{"key":"92421_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12529-012-9233-6","volume":"20","author":"M Merswolken","year":"2013","unstructured":"Merswolken, M., Deter, H.-C., Siebenhuener, S., Orth-Gom\u00e9r, K. & Weber, C. S. Anxiety as predictor of the cortisol awakening response in patients with coronary heart disease. Int. J. Behav. Med. 20, 461\u2013467. https:\/\/doi.org\/10.1007\/s12529-012-9233-6 (2013).","journal-title":"Int. J. Behav. Med."},{"key":"92421_CR6","doi-asserted-by":"publisher","first-page":"e0224451","DOI":"10.1371\/journal.pone.0224451","volume":"14","author":"C-C Tsai","year":"2019","unstructured":"Tsai, C.-C. et al. The association between psychological distress and angina pectoris: A population-based study. PLoS ONE 14, e0224451. https:\/\/doi.org\/10.1371\/journal.pone.0224451 (2019).","journal-title":"PLoS ONE"},{"key":"92421_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jacc.2010.03.034","volume":"56","author":"AM Roest","year":"2010","unstructured":"Roest, A. M., Martens, E. J., de Jonge, P. & Denollet, J. Anxiety and risk of incident coronary heart disease: A meta-analysis. J. Am. Coll. Cardiol. 56, 38\u201346. https:\/\/doi.org\/10.1016\/j.jacc.2010.03.034 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"92421_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/CM9.0000000000000215","volume":"132","author":"K Xia","year":"2019","unstructured":"Xia, K. et al. Comparing the effects of depression, anxiety, and comorbidity on quality-of-life, adverse outcomes, and medical expenditure in Chinese patients with acute coronary syndrome. Chin. Med. J. 132, 1045\u20131052. https:\/\/doi.org\/10.1097\/CM9.0000000000000215 (2019).","journal-title":"Chin. Med. J."},{"key":"92421_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1749-6632.1990.tb16910.x","volume":"600","author":"DS Charney","year":"1990","unstructured":"Charney, D. S., Woods, S. W., Krystal, J. H. & Heninger, G. R. Serotonin function and human anxiety disorders. Ann. N. Y. Acad. Sci. 600, 558\u2013572. https:\/\/doi.org\/10.1111\/j.1749-6632.1990.tb16910.x (1990) (discussion 572\u2013573).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"92421_CR10","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/ajh\/hpv047","volume":"28","author":"BE Cohen","year":"2015","unstructured":"Cohen, B. E., Edmondson, D. & Kronish, I. M. State of the art review: Depression, stress, anxiety, and cardiovascular disease. Am. J. Hypertens. 28, 1295\u20131302. https:\/\/doi.org\/10.1093\/ajh\/hpv047 (2015).","journal-title":"Am. J. Hypertens."},{"key":"92421_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pcad.2012.06.001","volume":"55","author":"WHW Tang","year":"2012","unstructured":"Tang, W. H. W. Biomarkers in cardiovascular diseases: How can the \u2018-omics\u2019 revolution be applicable at the bedside. Introduction. Prog. Cardiovasc. Dis. 55, 1\u20132. https:\/\/doi.org\/10.1016\/j.pcad.2012.06.001 (2012).","journal-title":"Prog. Cardiovasc. Dis."},{"key":"92421_CR12","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","volume":"122","author":"RW McGarrah","year":"2018","unstructured":"McGarrah, R. W., Crown, S. B., Zhang, G.-F., Shah, S. H. & Newgard, C. B. Cardiovascular metabolomics. Circ. Res. 122, 1238\u20131258. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311002 (2018).","journal-title":"Circ. Res."},{"key":"92421_CR13","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","volume":"126","author":"SH Shah","year":"2012","unstructured":"Shah, S. H., Kraus, W. E. & Newgard, C. B. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: Form and function. Circulation 126, 1110\u20131120. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.060368 (2012).","journal-title":"Circulation"},{"key":"92421_CR14","doi-asserted-by":"publisher","first-page":"e4202","DOI":"10.1002\/bmc.4202","volume":"32","author":"R Berkecz","year":"2018","unstructured":"Berkecz, R. et al. Plasma phospholipid profiling of a mouse model of anxiety disorder by hydrophilic interaction liquid chromatography coupled to high-resolution mass spectrometry. Biomed. Chromatogr. 32, e4202. https:\/\/doi.org\/10.1002\/bmc.4202 (2018).","journal-title":"Biomed. Chromatogr."},{"key":"92421_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jpsychires.2014.07.019","volume":"58","author":"MD Filiou","year":"2014","unstructured":"Filiou, M. D. et al. Behavioral extremes of trait anxiety in mice are characterized by distinct metabolic profiles. J. Psychiatr. Res. 58, 115\u2013122. https:\/\/doi.org\/10.1016\/j.jpsychires.2014.07.019 (2014).","journal-title":"J. Psychiatr. Res."},{"key":"92421_CR16","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.3390\/ijms21134784","volume":"21","author":"E Humer","year":"2020","unstructured":"Humer, E., Pieh, C. & Probst, T. Metabolomic biomarkers in anxiety disorders. Int. J. Mol. Sci. 21, 4784. https:\/\/doi.org\/10.3390\/ijms21134784 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"92421_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.freeradbiomed.2019.03.036","volume":"144","author":"S Zhong","year":"2019","unstructured":"Zhong, S. et al. An update on lipid oxidation and inflammation in cardiovascular diseases. Free Radic. Biol. Med. 144, 266\u2013278. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.03.036 (2019).","journal-title":"Free Radic. Biol. Med."},{"key":"92421_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1570159X15666171123201142","volume":"16","author":"JC Felger","year":"2018","unstructured":"Felger, J. C. Imaging the role of inflammation in mood and anxiety-related disorders. Curr. Neuropharmacol. 16, 533\u2013558. https:\/\/doi.org\/10.2174\/1570159X15666171123201142 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"92421_CR19","first-page":"3091","volume":"18","author":"P-Y Zhang","year":"2014","unstructured":"Zhang, P.-Y., Xu, X. & Li, X.-C. Cardiovascular diseases: Oxidative damage and antioxidant protection. Eur. Rev. Med. Pharmacol. Sci. 18, 3091\u20133096 (2014).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"92421_CR20","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","volume":"108","author":"M Naghavi","year":"2003","unstructured":"Naghavi, M. et al. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation 108, 1664\u20131672. https:\/\/doi.org\/10.1161\/01.CIR.0000087480.94275.97 (2003).","journal-title":"Circulation"},{"key":"92421_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","volume":"25","author":"CB Newgard","year":"2017","unstructured":"Newgard, C. B. Metabolomics and metabolic diseases: Where do we stand?. Cell Metab. 25, 43\u201356. https:\/\/doi.org\/10.1016\/j.cmet.2016.09.018 (2017).","journal-title":"Cell Metab."},{"key":"92421_CR22","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M111.008110","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways. Mol. Cell Proteomics https:\/\/doi.org\/10.1074\/mcp.M111.008110 (2011).","journal-title":"Mol. Cell Proteomics"},{"key":"92421_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00216-014-8262-1","volume":"407","author":"K Arnhard","year":"2015","unstructured":"Arnhard, K., Gottschall, A., Pitterl, F. & Oberacher, H. Applying \u2018Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra\u2019 (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry. Anal. Bioanal. Chem. 407, 405\u2013414. https:\/\/doi.org\/10.1007\/s00216-014-8262-1 (2015).","journal-title":"Anal. Bioanal. Chem."},{"key":"92421_CR24","doi-asserted-by":"publisher","first-page":"e008278","DOI":"10.1161\/JAHA.117.008278","volume":"7","author":"P Chan","year":"2018","unstructured":"Chan, P. et al. Novel phospholipid signature of depressive symptoms in patients with coronary artery disease. J. Am. Heart Assoc. 7, e008278. https:\/\/doi.org\/10.1161\/JAHA.117.008278 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"92421_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.comppsych.2016.05.005","volume":"69","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. A cross-sectional study to investigate the correlation between depression comorbid with anxiety and serum lipid levels. Compr. Psychiatry 69, 163\u2013168. https:\/\/doi.org\/10.1016\/j.comppsych.2016.05.005 (2016).","journal-title":"Compr. Psychiatry"},{"key":"92421_CR26","doi-asserted-by":"publisher","first-page":"112859","DOI":"10.1016\/j.psychres.2020.112859","volume":"286","author":"M Zimmerman","year":"2020","unstructured":"Zimmerman, M., Thompson, J. S., Diehl, J. M., Balling, C. & Kiefer, R. Is the DSM-5 Anxious Distress Specifier Interview a valid measure of anxiety in patients with generalized anxiety disorder: A comparison to the Hamilton Anxiety Scale. Psychiatry Res. 286, 112859. https:\/\/doi.org\/10.1016\/j.psychres.2020.112859 (2020).","journal-title":"Psychiatry Res."},{"key":"92421_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/occmed\/kqv054","volume":"65","author":"E Thompson","year":"2015","unstructured":"Thompson, E. Hamilton rating scale for anxiety (HAM-A). Occup. Med. 65, 601. https:\/\/doi.org\/10.1093\/occmed\/kqv054 (2015).","journal-title":"Occup. Med."},{"key":"92421_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fpsyt.2018.00525","volume":"9","author":"Y Ren","year":"2018","unstructured":"Ren, Y. et al. Chronic stress disturbs metabolome of blood plasma and urine in diabetic rats. Front. Psychiatry 9, 525. https:\/\/doi.org\/10.3389\/fpsyt.2018.00525 (2018).","journal-title":"Front. Psychiatry"},{"key":"92421_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.peptides.2006.07.027","volume":"28","author":"T Karl","year":"2007","unstructured":"Karl, T. & Herzog, H. Behavioral profiling of NPY in aggression and neuropsychiatric diseases. Peptides 28, 326\u2013333. https:\/\/doi.org\/10.1016\/j.peptides.2006.07.027 (2007).","journal-title":"Peptides"},{"key":"92421_CR30","doi-asserted-by":"publisher","first-page":"631","DOI":"10.5604\/17322693.1058890","volume":"67","author":"M \u015aliwi\u0144ska-Mosso\u0144","year":"2013","unstructured":"\u015aliwi\u0144ska-Mosso\u0144, M., Borowiecka, K. & Milnerowicz, H. Neuropeptides Y, YY, PP and their clinical significance. Postepy Hig. Med. Dosw. 67, 631\u2013636. https:\/\/doi.org\/10.5604\/17322693.1058890 (2013).","journal-title":"Postepy Hig. Med. Dosw."},{"key":"92421_CR31","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1517\/14728222.2011.628314","volume":"15","author":"G Wu","year":"2011","unstructured":"Wu, G. et al. Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin. Ther. Targets 15, 1317\u20131331. https:\/\/doi.org\/10.1517\/14728222.2011.628314 (2011).","journal-title":"Expert Opin. Ther. Targets"},{"key":"92421_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/5584_2019_427","volume":"1237","author":"P Shende","year":"2020","unstructured":"Shende, P. & Desai, D. Physiological and therapeutic roles of neuropeptide Y on biological functions. Adv. Exp. Med. Biol. 1237, 37\u201347. https:\/\/doi.org\/10.1007\/5584_2019_427 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"92421_CR33","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1177\/0269881116655321","volume":"30","author":"SD Hood","year":"2016","unstructured":"Hood, S. D., Bell, C. J., Argyropoulos, S. V. & Nutt, D. J. Don\u2019t panic. A guide to tryptophan depletion with disorder-specific anxiety provocation. J. Psychopharmacol. 30, 1137\u20131140. https:\/\/doi.org\/10.1177\/0269881116655321 (2016).","journal-title":"J. Psychopharmacol."},{"key":"92421_CR34","doi-asserted-by":"publisher","first-page":"e3498","DOI":"10.1097\/MD.0000000000003498","volume":"95","author":"CY Hsiao","year":"2016","unstructured":"Hsiao, C. Y. et al. The association between baseline subjective anxiety rating and changes in cardiac autonomic nervous activity in response to tryptophan depletion in healthy volunteers. Medicine 95, e3498. https:\/\/doi.org\/10.1097\/MD.0000000000003498 (2016).","journal-title":"Medicine"},{"key":"92421_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.neubiorev.2009.08.005","volume":"34","author":"BY Silber","year":"2010","unstructured":"Silber, B. Y. & Schmitt, J. A. J. Effects of tryptophan loading on human cognition, mood, and sleep. Neurosci. Biobehav. Rev. 34, 387\u2013407. https:\/\/doi.org\/10.1016\/j.neubiorev.2009.08.005 (2010).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"92421_CR36","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.neuroscience.2009.11.036","volume":"165","author":"K Isoda","year":"2010","unstructured":"Isoda, K. et al. Postnatal changes in serotonergic innervation to the hippocampus of methyl-CpG-binding protein 2-null mice. Neuroscience 165, 1254\u20131260. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.11.036 (2010).","journal-title":"Neuroscience"},{"key":"92421_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrd.2016.32","volume":"15","author":"DS Wishart","year":"2016","unstructured":"Wishart, D. S. Emerging applications of metabolomics in drug discovery and precision medicine. Nat. Rev. Drug Discov. 15, 473\u2013484. https:\/\/doi.org\/10.1038\/nrd.2016.32 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"92421_CR38","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cyto.2017.09.002","volume":"102","author":"K W\u00f3jcik-Pszczo\u0142a","year":"2018","unstructured":"W\u00f3jcik-Pszczo\u0142a, K. et al. Connective tissue growth factor regulates transition of primary bronchial fibroblasts to myofibroblasts in asthmatic subjects. Cytokine 102, 187\u2013190. https:\/\/doi.org\/10.1016\/j.cyto.2017.09.002 (2018).","journal-title":"Cytokine"},{"key":"92421_CR39","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.bbalip.2014.12.014","volume":"1052\u20131065","author":"CP M\u00fcller","year":"1851","unstructured":"M\u00fcller, C. P. et al. Brain membrane lipids in major depression and anxiety disorders. Biochim. Biophys. Acta 1052\u20131065, 2015. https:\/\/doi.org\/10.1016\/j.bbalip.2014.12.014 (1851).","journal-title":"Biochim. Biophys. Acta"},{"key":"92421_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12993-016-0091-2","volume":"12","author":"J Puurunen","year":"2016","unstructured":"Puurunen, J., Tiira, K., Lehtonen, M., Hanhineva, K. & Lohi, H. Non-targeted metabolite profiling reveals changes in oxidative stress, tryptophan and lipid metabolisms in fearful dogs. Behav. Brain Funct. 12, 7. https:\/\/doi.org\/10.1186\/s12993-016-0091-2 (2016).","journal-title":"Behav. Brain Funct."},{"key":"92421_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2019.02.020","volume":"284","author":"M Shiomi","year":"2019","unstructured":"Shiomi, M. et al. Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia. Atherosclerosis 284, 18\u201323. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.02.020 (2019).","journal-title":"Atherosclerosis"},{"key":"92421_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174574","volume":"12","author":"C-I Huang","year":"2017","unstructured":"Huang, C.-I. et al. Hyperlipidemia and statins use for the risk of new-onset anxiety\/depression in patients with head and neck cancer: A population-based study. PLoS ONE 12, e0174574. https:\/\/doi.org\/10.1371\/journal.pone.0174574 (2017).","journal-title":"PLoS ONE"},{"key":"92421_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/adb.12034","volume":"19","author":"JA Chester","year":"2014","unstructured":"Chester, J. A., Kirchhoff, A. M. & Barrenha, G. D. Relation between corticosterone and fear-related behavior in mice selectively bred for high or low alcohol preference. Addict. Biol. 19, 663\u2013675. https:\/\/doi.org\/10.1111\/adb.12034 (2014).","journal-title":"Addict. Biol."},{"key":"92421_CR44","first-page":"29","volume":"12","author":"IL Shvarts","year":"1972","unstructured":"Shvarts, I. L. & Kats, S. M. The state of the pentose-phosphate pathway of carbohydrate metabolism in ischemic heart disease. Kardiologiia 12, 29\u201332 (1972).","journal-title":"Kardiologiia"},{"key":"92421_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.psychres.2018.09.024","volume":"270","author":"G Fond","year":"2018","unstructured":"Fond, G. et al. Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort. Psychiatry Res. 270, 104\u2013110. https:\/\/doi.org\/10.1016\/j.psychres.2018.09.024 (2018).","journal-title":"Psychiatry Res."},{"key":"92421_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.bbr.2018.08.020","volume":"356","author":"K Sedaghat","year":"2019","unstructured":"Sedaghat, K. et al. Mesolimbic dopamine system and its modulation by vitamin D in a chronic mild stress model of depression in the rat. Behav. Brain Res. 356, 156\u2013169. https:\/\/doi.org\/10.1016\/j.bbr.2018.08.020 (2019).","journal-title":"Behav. Brain Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92421-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92421-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92421-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T09:54:50Z","timestamp":1670061290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-92421-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["92421"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-92421-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12897"}}